SEC Form 4 · accession 0001140361-18-019061
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronald Richard
Director
Period of report
Apr 17, 2018
Accepted (ET)
Apr 19, 2018 · 4:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 17, 2018 | M | 7,893 | $13.37 | A | 31,303 | D | |
| Common StockF1 | Apr 17, 2018 | S | 7,893 | $55.00 | D | 23,410 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2,F3 | $13.37 | Apr 17, 2018 | M | 7,893 | D | — | May 16, 2019 | Common Stock | 7,893 | 0 | D |
Explanation of responses
- F1The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard.
- F2Consists of an option granted under the company's stock incentive plan as amended and restated.
- F3The option grant is fully vested.
Remarks
Exhibit List: EX. 24.1 Power of Attorney